Search
Advanced search

Company search

Company/VAT no/Free text Country/City/Municipality

TURNOVER (x1000 DKK)

NET PROFIT (x1000 DKK)

EMPLOYEES

Share

Bergentoft Pharma Consulting AB

Closing information (x1000 DKK)

Closing information 2023/12 2022/12 2021/12
Turnover 1,333 More Arrow 1,373 Less Arrow 855
Financial expenses 5 Less Arrow 0 Equal arrow 0
Earnings before taxes 1,165 Less Arrow 846 Less Arrow 590
EBITDA 1,154 Less Arrow 846 Less Arrow 590
Total assets 2,673 Less Arrow 1,963 Less Arrow 1,235
Current assets 2,031 Less Arrow 1,295 Less Arrow 1,235
Current liabilities 420 More Arrow 512 Less Arrow 297
Equity capital 2,084 Less Arrow 1,348 Less Arrow 874
- share capital 34 Less Arrow 33 More Arrow 36
Employees (average) 2 Less Arrow 1 Equal arrow 1

Financial ratios

Fiscal year 2023/12 2022/12 2021/12
Solvency 78.0% Less Arrow 68.7% More Arrow 70.8%
Turnover per employee 666 More Arrow 1,373 Less Arrow 855
Profit as a percentage of turnover 87.4% Less Arrow 61.6% More Arrow 69.0%
Return on assets (ROA) 43.8% Less Arrow 43.1% More Arrow 47.8%
Current ratio 483.6% Less Arrow 252.9% More Arrow 415.8%
Return on equity (ROE) 55.9% More Arrow 62.8% More Arrow 67.5%
Change turnover -47 More Arrow 587 Less Arrow 406
Change turnover % -3% More Arrow 75% More Arrow 91%
Chg. No. of employees 1 Less Arrow 0 Equal arrow 0
Chg. No. of employees % 100% Less Arrow 0% Equal arrow 0%

Total value of public sale

Fiscal year 2023/12 2022/12 2021/12
Total value of public sale 0 Equal arrow 0 Equal arrow 0

Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank

The closing information is gathered directly from the companies or from Creditsafe.